Hassan, M. S., & Jawad, A. M. (2026). Assessment of Pathological Response to Neoadjuvant Therapy: Comparison Between Pertuzumab-Based and Non-Pertuzumab Protocols in HER2-Positive Breast Cancer. Middle Eastern Cancer and Oncology Journal, 2(3), 1-9. https://doi.org/10.61706/MECOJ160229